Results 241 to 250 of about 229,203 (309)
Antithrombin: Deficiency, Diversity, and the Future of Diagnostics
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt +2 more
wiley +1 more source
Liver Cirrhosis and In-Hospital Outcomes in Patients With Sickle Cell Crises. [PDF]
Gold-Olufadi S +14 more
europepmc +1 more source
ABSTRACT Functional DNA methylation abnormalities are a hallmark of human cancers and may be a promising biomarker for their early diagnosis. Moreover, the largest methylation differences can improve the sensitivity of noninvasive diagnoses of solid tumors.
Junsheng Zhao +6 more
wiley +1 more source
Early Prediction of Hepatic Decompensation in Cirrhosis Using Optimised XGBoost Models at the Initial Outpatient Hepatology Visit. [PDF]
Grubert Van Iderstine M +7 more
europepmc +1 more source
This multicenter retrospective study assessed preoperative immune checkpoint inhibitor (ICI) therapy in 17 hepatocellular carcinoma patients undergoing liver transplantation. All received at least one cycle of ICI‐based combination therapy before transplant and achieved a 76.5% objective response rate.
Huanquan Chen +7 more
wiley +1 more source
Ascitic fluid concentrations of fibronectin and cholesterol [PDF]
Gerbes, Alexander L. +3 more
core
Portal hypertension, a critical complication in chronic liver disease, has long relied on invasive hepatic venous pressure gradient measurement for definitive diagnosis. This study establishes that multifrequency three‐dimensional magnetic resonance elastography (3D‐MRE) can noninvasively quantify portal pressure, with splenic stiffness and loss ...
Bai Du +6 more
wiley +1 more source
Predictors of 30-Day Readmission in Patients With Cirrhosis: A Retrospective Cohort Study. [PDF]
Albusta N, Yusuf A, Alrahma H.
europepmc +1 more source

